The evolution of oncology payment models has been saved
Limited functionality available
The amount of money spent on oncology in the US is staggering. And that number will only continue to rise. So what can the health care industry do to improve the cost-effectiveness of cancer care? Our new report takes a closer look at the evolution of oncology payment models, the drivers of oncology spending, and how value-based payment models could affect new treatments.